# Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes

> **NCT04304300** · — · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 80 (actual)

## Conditions studied

- Astrocytoma, Grade II
- Astrocytoma, Grade III
- Oligodendroglioma
- Oligodendroglioma, Anaplastic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04304300
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-06-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04304300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04304300, "Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04304300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*